4 stories mentioning HKG:9877Updated 2d ago
Every FINWIRES story that references HKG:9877, newest first.
Jenscare Scientific's (HKG:9877) JensClip Transcatheter Valve Repaire System obtained registration approval from China's National Medical Products Administration.The product is designed to treat patients with severe mitral regurgitation, a Tuesday bourse filing showed.
Jenscare Scientific's (HKG:9877) LuX-Valve Plus transvenous tricuspid valve replacement system has received approval from Hong Kong's Department of Health, according to a Friday Hong Kong bourse filing.The medical device company plans to commercialize the device in Hong Kong, while LuX-Valve Plus has already obtained regulatory approvals in countries and regions across Europe, the Middle East and Asia-Pacific, the filing said.Shares of the company fell over 2% in recent trade.
Jenscare Scientific (HKG:9877) expects to generate about 63 million yuan to 65 million yuan in revenue for the first half of 2026, up about 385% to 400% from the same period a year earlier, according to a Monday Hong Kong bourse filing.The company attributed the expected growth mainly to stronger commercialization of its Ken-Valve transcatheter aortic valve replacement system and increased overseas clinical use of its structural heart interventional products.Jenscare expects to release its interim results in August.
Jenscare Scientific (HKG:9877) said its Ken-Valve Transcatheter Aortic Valve Replacement System received approval from Hong Kong's Department of Health, according to a Monday bourse filing.Ken-Valve is used to treat aortic regurgitation and combined aortic stenosis, the filing said.
